MVA-BN: Began Phase I testing

Bavarian Nordic Research Institute A/S (CSE:BNRI), Glostrup, Denmark Product: MVA-BN Business: Infectious diseases Therapeutic category: Immune stimulation Target: Immune cells Description: Modified ...